| Product Code: ETC9945234 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Generic Drug Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Generic Drug Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Generic Drug Market - Industry Life Cycle |
3.4 United Kingdom (UK) Generic Drug Market - Porter's Five Forces |
3.5 United Kingdom (UK) Generic Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Generic Drug Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.7 United Kingdom (UK) Generic Drug Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 United Kingdom (UK) Generic Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United Kingdom (UK) Generic Drug Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 United Kingdom (UK) Generic Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives to promote the use of generic drugs and reduce healthcare costs. |
4.2.2 Patent expirations of major branded drugs, leading to opportunities for generic drug manufacturers. |
4.2.3 Growing demand for cost-effective healthcare solutions among the aging population in the UK. |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for generic drugs, leading to delays in market entry. |
4.3.2 Price erosion due to intense competition among generic drug manufacturers. |
4.3.3 Limited consumer awareness and trust in generic drugs compared to branded counterparts. |
5 United Kingdom (UK) Generic Drug Market Trends |
6 United Kingdom (UK) Generic Drug Market, By Types |
6.1 United Kingdom (UK) Generic Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Simple Generics, 2021- 2031F |
6.1.4 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Super Generics, 2021- 2031F |
6.2 United Kingdom (UK) Generic Drug Market, By Brand |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Pure Generic, 2021- 2031F |
6.2.3 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Branded Generic, 2021- 2031F |
6.3 United Kingdom (UK) Generic Drug Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Central Nervous System (CNS), 2021- 2031F |
6.3.3 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.3.4 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.3.5 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.6 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.3.7 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Generic Drug Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Topical, 2021- 2031F |
6.4.4 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.5 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Generic Drug Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 United Kingdom (UK) Generic Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Generic Drug Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Generic Drug Market Export to Major Countries |
7.2 United Kingdom (UK) Generic Drug Market Imports from Major Countries |
8 United Kingdom (UK) Generic Drug Market Key Performance Indicators |
8.1 Prescription market share of generic drugs compared to branded drugs. |
8.2 Number of generic drug approvals and launches in the UK market. |
8.3 Average cost savings achieved by healthcare providers and patients through the use of generic drugs. |
9 United Kingdom (UK) Generic Drug Market - Opportunity Assessment |
9.1 United Kingdom (UK) Generic Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Generic Drug Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.3 United Kingdom (UK) Generic Drug Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 United Kingdom (UK) Generic Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United Kingdom (UK) Generic Drug Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 United Kingdom (UK) Generic Drug Market - Competitive Landscape |
10.1 United Kingdom (UK) Generic Drug Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Generic Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here